Back to Search Start Over

Supplementary Figure 8 from EMD 1214063 and EMD 1204831 Constitute a New Class of Potent and Highly Selective c-Met Inhibitors

Authors :
Andree Blaukat
Oliver Schadt
Frank Stieber
Ulrich Pehl
Frank Jaehrling
Dieter Dorsch
Michael Meyring
Ulrich Grädler
Claus Fittschen
Claudia Wilm
Christine Knuehl
Manja Friese-Hamim
Bettina Faden
Friedhelm Bladt
Publication Year :
2023
Publisher :
American Association for Cancer Research (AACR), 2023.

Abstract

PDF file - 184K, EMD 1214063 and EMD 1204831 display anti-tumor activity in HGF-dependent and HGF-independent xenograft tumor models. Mice bearing subcutaneous tumors derived from the human gastric Hs746T cell line (A and B) or the glioblastoma U87MG cell line (C and D) were administered daily the indicated doses of EMD 1214063 (A and C), EMD 1204831 (B and D), or vehicle for the indicated treatment duration. Each data point represents the mean � SD of the calculated tumor volumes observed in experimental groups including ten mice. Statistical significance was evaluated by one-way ANOVA (Kruskal-Wallis, Dunn's post test). Asterisks indicate statistically significant differences between treated and control experimental groups (P≤0.05).

Details

Database :
OpenAIRE
Accession number :
edsair.doi.dedup.....03592926e46a69b8ef9743e7c67128ac